Co-registration of optical coherence tomography and X-ray angiography in percutaneous coronary intervention. The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) fusion study  by Hebsgaard, Lasse et al.
International Journal of Cardiology 182 (2015) 272–278
Contents lists available at ScienceDirect
International Journal of Cardiology
j ourna l homepage: www.e lsev ie r .com/ locate / i j ca rdCo-registration of optical coherence tomography and X-ray angiography
in percutaneous coronary intervention. The Does Optical Coherence
Tomography Optimize Revascularization (DOCTOR) fusion study☆Lasse Hebsgaard a, Troels Munck Nielsen a, Shengxian Tu b, Lars Romer Krusell a, Michael Maeng a,
Karsten Tange Veien a, Bent Raungaard a, Christian Juhl Terkelsen a, Anne Kaltoft a, Johan H.C. Reiber b,
Jens Flensted Lassen a, Evald Høj Christiansen a, Niels Ramsing Holm a,⁎
a Department of Cardiology, Aarhus University Hospital, Skejby, Denmark
b Division of Image Processing, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands☆ All authors take responsibility for all aspects of the reli
the data presented and their discussed interpretation.
⁎ Corresponding author at: Department of Cardiolog
Skejby, Brendstrupgaardsvej 100, 8200 Aarhus N, Denma
E-mail address: niels.holm@ki.au.dk (N.R. Holm).
http://dx.doi.org/10.1016/j.ijcard.2014.12.088
0167-5273/© 2015 The Authors. Published by Elsevier Irea b s t r a c ta r t i c l e i n f oArticle history:
Received 1 October 2014
Received in revised form 8 December 2014
Accepted 25 December 2014
Available online 27 December 2014
Keywords:
Optical coherence tomography
Percutaneous coronary intervention
Angiography
Coronary heart disease
Co-registration
Quantitative coronary angiography
Background: Intracoronary imaging provides accurate lesion delineation and precisemeasurements for sizing and
positioning of coronary stents. During percutaneous coronary intervention (PCI), it may be challenging to iden-
tify corresponding segments between intracoronary imaging and angiography. Computer based online co-
registration may aid the target segment identiﬁcation.
Methods: The DOCTOR fusion study was a prospective, single arm, observational study including patients admit-
ted for elective PCI. Optical coherence tomography (OCT)was acquiredpre-stent implantation for sizing of stents.
The operator subsequently indicated on the angiogram the target area as identiﬁed by OCT. Computer based co-
registration was performed on-line immediately after pre-stent acquisition to assess feasibility. The cumulated
numerical difference between operator based, and computer based co-registrationwas assessed as the “Operator
Registration Error”. The operator implanted the stent blind to the co-registrated angiogram. The difference be-
tween the co-registered stent border positions and the actual stent deployment border positions was the “Geo-
graphic Miss Distance”.
Results: Twenty-two patients were included in the study. Two patients were excluded due tomissing pre or post-
OCT acquisitions. Online co-registration pre-stenting was successful in all analyzed cases. The mean “Operator
Registration Error”was 5.4 ± 3.5 mm. The mean “Geographic Miss Distance”was 5.4 ± 2.6 mm.Without access
to the computer-based co-registration, segments of the target lesion indicated on OCT were left uncovered by
stent in 14 patients (70%).
Conclusion: Computer based online co-registration of OCT and angiography is feasible. Frequent inaccuracies in
operator based registration indicate that computer aided co-registration may reduce errors in corresponding
OCT ﬁndings to the angiogram.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Percutaneous coronary intervention (PCI) for atherosclerotic disease
has developed over the past decades to a standard treatment with fa-
vorable prognosis for most indications. Sizing and positioning of stents
may be aided by intracoronary imaging. The use of intracoronary imag-
ing varies from no use, to use in complex procedures and in some cen-
ters and countries almost routine use in all cases.ability and freedom from bias of
y, Aarhus University Hospital,
rk.
land Ltd. This is an open access article uRoutine guiding of PCI by intracoronary imaging has potential ad-
vantages [1,2] but reduction in major adverse cardiac events by routine
use of intravascular ultrasound (IVUS) guidance has not been demon-
strated in well powered randomized trials [3–5] though a recent
meta-analysis suggested positive effects when including both RCTs
and observational studies [6]. Optical coherence tomography (OCT)
for guiding PCI is feasible [7] but potential clinical value is unknown.
Incorrect anatomical correspondence of intracoronary imaging and
the angiogram during PCI may lead to incorrect assessment of the
patho-anatomy and erroneous sizing and positioning of stents. In case
of angiographic ambiguity, there is a risk of assessing thewrong location
on IVUS or OCTmaking thewrong diagnosis of the pathology. Likewise,
in use of IVUS or OCT for stent positioning, there is a risk that the target
area is mismatched to the angiogram e.g.in diffuse atheroscleroticnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Co-registration software—working view. User interface of QangioOCT RE (Medis Specials, Leiden, NL). Middle image shows the longitudinal view of the OCT acquisition. Green
markers represent the stent boarders and the corresponding cross sections are shown to the right. The lower left quadrant shows the 3D reconstruction of the vessel based on the two
angiographic projections shown in the upper two quadrants.
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imaging and may even be detrimental.
To link intracoronary imaging and angiography during PCI, the
operator must identify corresponding structures and segments and
therebymindmap the intracoronary scanning images to the angiogram.Fig. 2. Co-registrated angiogram. After co-registration and identiﬁcation of the stent landing zo
boarders and correspondingmeasurements based onOCT and 3DQCA. PD andDDare the proxim
and best visibility of the lesion is shown.Computer based co-registration of intracoronary scanning modalities
and X-ray angiography may aid correct matching between the two
modalities.
Herewe present the ﬁrst clinical evaluation of co-registration of OCT
and X-ray angiography. We aimed to evaluate if computer based onlinene using OCT, the angiographic working projection is presented with co-registrated stent
al and distal diameters, respectively. Optimal projection angle for the least foreshortening
Table 1
Baseline characteristics.
Baseline clinical characteristics N (%) or mean ± SD
Male 17 (85%)
Age (yrs) 60.75 ± 10.86
Smoker (1 missing)
Never 8 (40%)
Current 4 (20%)
Former 7 (35%)
Hypertension 12 (60%)
Hypercholesterolemia 11 (55%)
Diabetes mellitus 2 (10%)
Prior PCI 3 (15%)
Indication
Stable angina pectoris 13 (65%)
Unstable angina pectoris 0 (0%)
Non-STEMI 7 (35%)
PCI: percutaneous coronary intervention. Non-STEMI: Non-ST-elevations myocardial
infarction.
274 L. Hebsgaard et al. / International Journal of Cardiology 182 (2015) 272–278co-registration of OCT and angiography was feasible. We examined if
co-registration had the potential for improving positioning of stents
compared to operator mindmapping of OCT to angiography during PCI.
2. Methods
The DOCTOR fusion studywas a prospective, observational, single arm study. Patients
admitted for elective or subacute percutaneous coronary intervention were offered inclu-
sion if OCTwas not contraindicated. Inclusion criteriawere: at least 18 y/o, able to provide
written informed consent, maximum 2 lesions requiring treatment, maximum lesion
length 40 mm (visually assessed). Exclusion criteria were: life expectancy less than
1 year, pregnancy or possible pregnancy, impaired kidney function (creatinine N 100
μmol/L), ST-elevation myocardial infarction within 7 days, cardiogenic shock, or severely
tortuous vessels. The study was conducted according to the Declaration of Helsinki and
the study was approved by the Mid Jutland Ethics Committee for Biomedical Research
and The Danish Data Protection Agency.
2.1. Study procedure
Percutaneous coronary intervention was performed according to the standard best
practice. OCT was acquired before and after stent implantation by protocol. Use of OCT
for guiding the intervention pre and post-stenting was allowed at operator's discretion.
Co-registration of angiography and OCT was performed immediately after pre-stenting
OCT. The co-registered angiogram was not available to the operator.
2.2. Indication of stent landing zone
Upon identifying the angiographic working projection, the operator marked on a
print-out paper image of the angiogram the coronary segment he intended to cover by
stenting. Based on visual assessment, the operator suggested length and diameter of the
stent needed to cover the lesion. OCT pullbacks were recommended to be performed
after predilatation to ensure that the image wire would be non-occlusive and to be able
to assess extent of dissections inﬂicted by predilatation. Acquisition of OCT (54 mm,
20mm/s, Illumien, St. JudeMedical)was evaluatedby theoperator on a regular OCT acqui-
sition console identifying the landing zone and adjusting stent borders to the nearest, lon-
ger available stent length. The operator thenmarked on the paper image of the angiogram
where he believed the stent borders corresponding to the OCT decision should be.
2.3. Lesion segment identiﬁcation
Angiographic assessments of stent size and position were based on visual assessment
using integrated size comparisons, length of opaquewire sections and balloon lengths. Le-
sion segment identiﬁcation by OCT was performed by the operator. The aimwas to coverFig. 3.Deﬁnitions. Deﬁnitions used in the analysis. Operator Registration Error measures operato
regular OCT console. GeographicalMiss Distance is themismatch of the co-registration based LZ a
between visual determined stent length determined by angiography versus by OCT. Letter b: O
lesion markers on OCT, co-registrated (blue), d: Actual stent position (red). Subscripts p and d rsegmentswithminimal luminal area and adjacent segments b2.5mm2, areas of dissection
and areas of ruptured plaque, and to avoid stenting healthy segments and across side
branches if not needed. Partial stent coverage of major lipid plaques in the edge zone
was to be avoided.2.4. Co-registration
Immediately after obtaining theworking projection and a projection at least 25° apart,
DICOM runswere exported to an imagingworkstation. After correction for system distor-
tion, a 3D angiographic reconstruction of the target vessel was rendered from vessel con-
tours detected automatically on the two corresponding projections using a validated
software (QAngio XA 3D straight, Medis Special, Leiden, NL) [8–10]. The pre-stenting
OCT pullback was transferred to the imaging workstation containing the stent borders
as indicatedby the operator on theOCT console. Co-registrationwasperformedby indicat-
ing a common landmark e.g. the same side branch on the angiogram and on the OCT pull-
back (Fig. 1). To evaluate if co-registration was correct, correspondence of another,
preferably distant landmark was evaluated. The angiogram in working projection with
co-registered landing zone and size measurements was then available (Fig. 2). Co-
registration was performed using a validated software (QAngioOCT RE, Medis Specials,
Leiden, NL) [8,11].rs' error in predicting the landing zone (LZ) on angiography (XA) after marking it using the
nd the actual stent edge position. Operator Stent Length DecisionDifference is the difference
perator markers on angiogram based on OCT without co-registration (yellow), c: Operator
epresent proximal and distal markers respectively.
Table 2
Procedural characteristics.
Procedural characteristics
Study lesion location
RCA 9 (45%)
LMA 1 (5%)
Cx 2 (10%)
LAD 8 (40%)
Diameter stenosis % (visual assessment) 85.2 ± 10.4
Calciﬁed lesion 4 (20%)
Predilatation before OCT 17 (85%)
Entire lesion obtained by OCT pullback 18 (90%)
Successful co-registration (feasibility) 20 (100%)
Correct co-registration in ﬁrst attempt (procedural) 19 (95%)
Stent type
Nobori 8 (40%)
Osiro 7 (35%)
Other 5 (25%)
Number of stents 1.10 ± 0.31
Final OCT 20 (100%)
Procedural success 100%
Contrast use, including OCT acquisition (mL) 131.75 ± 43
Fluoro time (minutes) 8.65 ± 3.87
Procedure time (minutes) 39.65 ± 9.82
Operator overruled OCT assessment 2 (10%)
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Actual treatment was performed as normal best practice and as such not altered by
the study. Use of pre-stenting OCT measurements for actual treatment was performed at
the discretion of the operator andwas noted. The angiogramwith co-registered stent bor-
ders was not available to the operator. Post-stenting OCT acquisitions were available for
evaluation of ﬁnal result at operator's discretion.
2.6. Endpoint deﬁnitions
Feasibility was achieved when the correct co-registered angiogram in the working
projection including the stent borders was shown during the procedure.
“Operator Registration Error”was the cumulated numerical difference in positions of
the operator'smindmapped landing zone on the angiogram as corresponding to the stent
borders indicated on OCT, compared to the computer based co-registration results. See
Fig. 3.
“Geographic Miss Distance”was the cumulated numerical difference between the co-
registrated OCT based landing zone and the actual stent landing position assessed by co-
registrated post-stent OCT.
“Operator Stent Length Decision Difference”was the difference between operator de-
termined stent length by angiography versus by OCT.
“Operator Stent Diameter Decision Difference” was the difference between the nom-
inal stent diameter determined by the operator based on angiography versus by OCT.
Procedural success: TIMI ﬂow III and b30% residual stenosis by visual assessment.
Core lab analysis was performed using QAngioOCT RE, QAngio XA 3D RE (Medis
Specials, Leiden, NL) and OPTIS ORW (St. Jude, St. Paul, MN, USA).
3. Results
A total of 22 patients were included in the study. Two patients were
excluded from analysis, one due to missing pre-stent OCT and one due
to missing post-stent OCT. Pre-stent co-registration was successful in
the latter patient but ﬁnal OCTwas not acquired due to severe coronary
spasms. Baseline clinical characteristics are shown in Table 1. One third
of procedures were indicated by stabilized myocardial infarction (non-
STEMI) and the remaining had stable angina pectoris. Pre-stent OCT
was performed after predilatation in 85% of cases and the OCT pullback
did not cover the entire lesion in 5% of cases. Mean 1.1 ± 0.3 stent was
implanted (Table 2).
3.1. Feasibility
In the 20 patients entering analysis, full co-registrationwas achieved
during the procedure. Incorrect registration by non-matching land-
marks occurred in one case and was immediately identiﬁed by the sec-
ond landmark check and corrected. Co-registration andmatching of onepost interventionOCT pullbackwas not possible due to a cardiacmotion
artifact causing 10 mm of the same vessel segment to appear twice in
the OCT acquisition. There were no procedural clinical events.
3.2. Stent length and position
Fig. 4 shows schematic the segments to be covered by stent as deter-
mined 1) by OCT after computer co-registration, 2) by OCT after opera-
tor co-registration, 3) by visual assessment, and 4) shows the actual
stent position. Operator Registration Error was 5.4 ± 3.4 [0.8; 14] mm
[absolute range], Geographic Miss Distance was 5.3 ± 2.6 [1.6; 10.8]
mm. In 14 out of the 20 analyzed patients, one or more lesion segment
areas marked on OCT were uncovered by stent. Uncovered OCT deter-
mined lesion area longer than 2 mm was detected in 6 patients. The
stent diameter by angiographic decision compared to OCT guiding was
equal in 75% of cases 0.5 mm smaller in 5%, and 0.5 mm larger in 20%
of cases.Mean stent lengthwhen decided by visual assessment of angio-
graphic images was 22.5 ± 8.5 mm, by OCT 22.3 ± 8.7 mm and actual
implanted stent length was 22.4 ± 5.7 mm (Table 3).
4. Discussion
This is the ﬁrst systematic clinical evaluation of online co-registration
of angiography and OCT. We found that co-registration of pre-stent OCT
and angiographywas feasible during PCI using the investigated approach.
Landing zones identiﬁed using OCT and transferred to the angiogram by
the operator, differed 5.4 ± 2.6 mm in cumulated position length differ-
ence compared to computer based co-registration. Without access to
the co-registrated landing zone, parts of the OCT-identiﬁed lesion area
to be covered by stent, were left uncovered in 70% of the investigated
lesions.
4.1. Potential clinical implications of co-registration
Clinical co-registration of angiography and intracoronary imaging
may be an important tool to reduce the risk of incorrect correspondence
with potential serious consequences but also to fully exploit the beneﬁts
of the various intra coronary scanningmodalities. The registration is im-
portant in both directions enabling 1) correct intracoronary diagnosis of
ambiguous segments identiﬁed on the angiogram and 2) correct trans-
fer to the angiogram of delimited lesion segments and other features
identiﬁed by intracoronary modalities. Despite the simple lesions
assessed in our study, a high rate of incorrect operator matching result-
ed in uncovered lesion area in 70% of cases. Although the magnitude of
clinical impact of uncovered lesion area cannot be assessed by this ma-
terial it is an indication that even in simple lesions the transfer of
intracoronary imaging information may be challenging.
4.2. Lesion area identiﬁcation by OCT
Guiding of PCI by IVUS or OCT has shown promising, but not conﬁr-
matory results in studies ﬂawed by unclear treatment criteria, mix of
high- and low-risk populations and lack of randomization in most pos-
itive studies [12–17]. Speciﬁc high-risk lesion groups as leftmain lesions
may beneﬁt from routine use of intracoronary imaging as also recom-
mended in European and US guidelines [18–22]. The OCT criteria for
sizing and positioning the stent in non-left main vessels applied in the
present study lack validation but were proposed by synthesis of evi-
dence [23–27] and clinical experience. In 10% of the study procedures,
the operators expressed disbelief in the size and position of the segment
to be treated as assessed by OCT. Longer stents were implanted at
operator's discretion in those cases. Still the mean stent length as sug-
gested by visual assessment, by OCT and the actual implanted stent
was numerically similar. Thus guiding by OCT did not increase stent
length in this study. Co-registrated OCT might also help reducing the
number of stents implanted owing to improved sizing and positioning.
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Table 3
Stent sizing.
Lesion by visual assessment Stent size by visual assessment Stent size by OCT assessment Implanted stent, nominal Implanted stent, actualb
Diameter 3.47 ± 0.49a 3.31 ± 0.53 3.24 ± 0.46 3.24 ± 0.45 3.58 ± 0.45
Length 21.4 ± 7.76 22.45 ± 8.48 22.30 ± 8.70 22.35 ± 5.65 –
Mean sizes based on visual assessment of X-ray angiography, stent sizes by OCT assessment and implanted stent sizes. The length is assumed to be equal to the nominal size of the im-
planted stent.
a Reference size.
b Diameter according to balloon pressure.
277L. Hebsgaard et al. / International Journal of Cardiology 182 (2015) 272–278In the present study including only simple lesions we did not expect
major differences between guiding methods but still found differences
betweenmodalities as shown by themean cumulated numerical differ-
ence in lesion position of 3.5 mm ranging up 11 mm. For less experi-
enced operators and in complex lesion subsets including long diffuse
lesions the difference between guiding methods may be even larger.
4.3. Feasibility
For optimal end-user experience co-registration must be precise,
simple, fast, and feasible in almost all cases. Different technical ap-
proaches to co-registration all have trade-offs in terms of these criteria.
Clinical acceptable accuracy have been reported for a number of
systems [11,28–30] but no other co-registration system have been
systematically clinically evaluated for online use limiting the knowledge
of achieved feasibility. The evaluated system is based on a three-
dimensional quantitative coronary angiography (3D QCA) reconstruc-
tion of two angiographic projections. Measurements derived automati-
cally by the 3D QCA are co-presented along the OCT data to aid stent
sizing in the evaluated solution. This approach also provides automatic
calculation of optimal projection angle, detection of overlap for optional
projections, and sizing according to 3DQCAmeasurements if OCT is not
acquired. Methods using one or two point co-registration between 2D
angiography and OCT may be fast but may also be limited in accuracy
due to foreshortening in the angiogram [31]. Methods requiring contin-
uous angiographic detection of a moving marker on the imaging wire
[29] may provide fast co-registration with limited user interaction. In
co-registration of IVUS the marker to detect moves at up to 1 mm/s
whereas for OCT, reliable detection of a marker moving at up to
40 mm/s on the angiogram during ﬂushing with contrast may require
high angiographic frame rates and might be sensitive to overlapping
vessels. Feasibility of such approach for OCT remains to be evaluated.
4.4. Requirements of scanning modalities
We studied only short and simple lesions making the OCT pullback
length of 54 mm sufﬁcient in all but one case. Co-registration may be
even more important in long diffuse lesions without clear landmarks
where longer OCT pullbacks are needed. One-point registration may
be sensitive to cardiac motion artifacts and wire tension movements
that vary in size and may be considerable. The use of multiple land-
marks might improve the accuracy in the co-registration at an expense
of more user interaction. Optional two-point registration has been
added to the tested solution after ﬁnalizing the study. Despite potential
advantages, the present cost of imaging catheters prevents routine use
in most health care systems [32].
4.5. Universal co-registration
The overall feasibility of co-registration may be increased by full
integration of a universal platform in angiographic equipment. SuchFig. 4. Schematic lesion level results.Longitudinal results for all included patients. Green lines ind
dicted stent landing zone (LZ) based on OCT, without using co-registration. Gridded area (and
tration. The red lines indicate the actual stent position. *marks operator overruling OCT stent siz
increasing the apparent length of the 24 mm stent to 42 mm. Measurements of actual stent pocommon platform should enable registration to any modality with lon-
gitudinal information relevant to the interpretation of the angiogram.
Intracoronary imaging modalities but also motorized FFR pullback and
non-invasive imaging modalities should be connectable. The applica-
tion tested featured registration to IVUS [11], near infrared scans
(NIRS) and constant speed FFR pullbacks [33] though only the feasibility
of OCT registration was evaluated.5. Limitations
The studywas an explorative studywith a small sample size limiting
the information on the utility in various lesion subsets. The observation-
al design did not provide conﬁrmatory data on feasibility of OCT guided
PCI. Randomized trials are needed to assess clinical impact of co-
registration, though such comparison may be obsolete if fully integrat-
ed, feasible, fast and user-friendly co-registration becomes available.
Carefully designed randomized trials of co-registrated OCT versus angi-
ography for guiding treatment of complex lesions may however be
appropriate as the optimized co-registrated use of OCT may be neces-
sary for showing clinical beneﬁt in routine guiding. The applied co-
registration software was a research version with a pre-clinical user in-
terface operated by research fellows. The feasibility of such approach
applies to labs staffed with technicians. This emphasizes the need for
integration and user interface optimization before entering routine clin-
ical practice.6. Conclusion
Computer based online co-registration of OCT and angiography is
feasible. High rate of inaccuracy in corresponding OCT ﬁndings to the an-
giogram was detected indicating that computer based co-registration
may improve the utility of intracoronary imaging.Conﬂict of interest
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